11 Sep Section 36 approval – KLACID XL
Posted at 13:49h in
The DHCPL is intended to inform healthcare professionals that Abbott Labs is experiencing a delay in production from the manufacturing site and anticipates shortages of Klacid XL in emerging markets.
Download latest version
Document Number: DHCPL
Date Updated: 04/09/2023
File Type: pdf
Category: Communication To Health Care Professionals